Postdoctoral researcher
Dr. XU Wenye
PhD
Postdoctoral Fellow
Department of Anaesthesia and Intensive Care
The Chinese University of Hong Kong
For details about citations arising from my publications and links to online versions of some of the publications, refer to: https://orcid.org/0009-0002-4646-4823
Publications
(*corresponding author, ^co-first author)
- Xu W*, Su P*, et al; In vivo Imaging of a Novel Strain of Bacteroides fragilis via Metabolic Labeling. Front Microbiol. 2018 Oct 1;9:2298.[IF2022 =5.2]
- Fang S*, Zhang L*, Liu Y*, Xu W*, et al; Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19. Brief Bioinform. 2021 Mar 22;22(2):1466-1475. [IF2022= 9.5]
- Zhang L, Zhan H, Xu W, Yan S, et al; The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol. 2021 Sep 23;14:17562848211047130. [IF2022= 4.2]
- Xu W*, Liu Y*, Zou X*, Luo H*, Wu W*, et al; Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response. Front Immunol. 2022 Jan 4;12:785599. [IF2022= 7.3]
- Sun X, Liu Y, Huang Z, Xu W, et al; SARS-CoV-2 non-structural protein 6 triggers NLRP3- dependent pyroptosis by targeting ATP6AP1. Cell Death Differ. 2022 Jun;29(6):1240-1254. doi: 10.1038/s41418-021-00916-7. Epub 2022 Jan 8. [IF2022=12.4]
- Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, et al; Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022 Feb;162(2):548-561.e4. [IF2022= 29.4]
Last updated on 26-05-2026